en

PRODUCT DETAIL

Gemcitabine Kabi 38 mg/ml koncentrát na infúzny roztok

Code 4150B
MA number 44/0186/15-S
Product Form: con inf 1x26,3 ml/1000 mg (liek.inj.skl.)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
MAH, country: Fresenius Kabi s.r.o., Czechia
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01B ANTIMETABOLITES
L01BC Pyrimidine analogues
L01BC05 Gemcitabine
Shelf life: 24
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(3) hybrid application
MA issued: 22.05.2015
Pediatric posology: Yes
SPC: SPC_Gemcitabine Kabi 38 mg_ml koncentrát na infúzny roztok _06.2024.pdf  
PIL: PIL_Gemcitabine Kabi 38 mg_ml koncentrát na infúzny roztok_06.2024.pdf  
Safety feature Yes
Data update: 20.06.2024
eu-flag.png sk-flag.png